DAFTAR PUSTAKA

1. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. Jul
30 1998;339(5):313-20. [Medline].
2. Koonin LM, MacKay AP, Berg CJ, et al. Pregnancy-related mortality
surveillance--United States, 1987-1990. MMWR CDC Surveill Summ. Aug
8 1997;46(4):17-36. [Medline].
3. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and
management of preeclampsia. JAMA. Jun 26 2002;287(24):3183-6. [Medline].
4. Taylor RN, de Groot CJ, Cho YK, et al. Circulating factors as markers and
mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod
Endocrinol. 1998;16(1):17-31. [Medline].
5. Redman
CW,
Sargent
IL. Latest
advances
in
understanding
preeclampsia. Science. Jun 10 2005;308(5728):1592-4. [Medline].
6. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of
human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause
of defective endovascular invasion in this syndrome?. J Clin Invest. May
1 1997;99(9):2152-64. [Medline].
7. Friedman SA, Schiff E, Emeis JJ, et al. Biochemical corroboration of
endothelial involvement in severe preeclampsia. Am J Obstet
Gynecol. Jan 1995;172(1 Pt 1):202-3. [Medline].
8. American College of Obstetricians and Gynecologists. Hypertension in
pregnancy. ACOG Technical Bulletin No. 219. Washington DC: 1996.
9. ACOG. Committee on Practice Bulletins-Obstetrics. Diagnosis and
management of preeclampsia and eclampsia. Obstet Gynecol. 2001;98:159-67.
10. Report of the National High Blood Pressure Education Program Working
Group on High Blood Pressure in Pregnancy. Am J Obstet
Gynecol. Jul 2000;183(1):S1-S22. [Medline].
11. Waugh JJ, Clark TJ, Divakaran TG, et al. Accuracy of urinalysis dipstick
techniques in predicting significant proteinuria in pregnancy. Obstet
Gynecol. Apr 2004;103(4):769-77. [Medline].

12. Durnwald C, Mercer B. A prospective comparison of total protein/creatinine

ratio versus 24-hour urine protein in women with suspected preeclampsia. Am
J Obstet Gynecol. Sep 2003;189(3):848-52. [Medline].
13. Chesley
LC. Hypertensive
Disorders
AppletonCenturyCrofts. New York: 1978.

in

Pregnancy,

14. Fisher KA, Luger A, Spargo BH, et al. Hypertension in pregnancy: clinicalpathological
correlations
and
remote
prognosis. Medicine
(Baltimore). Jul 1981;60(4):267-76. [Medline].
15. Barron WM, Heckerling P, Hibbard JU, et al. Reducing unnecessary
coagulation testing in hypertensive disorders of pregnancy. Obstet
Gynecol. Sep 1999;94(3):364-70. [Medline].
16. Sibai BM. Diagnosis, controversies, and management of the syndrome of
hemolysis, elevated liver enzymes, and low platelet count. Obstet
Gynecol. May 2004;103(5 Pt 1):981-91. [Medline].
17. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet
Gynecol. Feb 2005;105(2):402-10. [Medline].
18. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy
nulliparas who developed hypertension. Calcium for Preeclampsia Prevention
Study Group. Obstet Gynecol. Jan 2000;95(1):24-8. [Medline].
19. Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are
significantly higher in severe gestational hypertension than in mild
preeclampsia. Am J Obstet Gynecol. Jan 2002;186(1):66-71. [Medline].
20. Barton JR, Witlin AG, Sibai BM. Management of mild preeclampsia. Clin
Obstet Gynecol. Sep 1999;42(3):455-69. [Medline].
21. Which anticonvulsant for women with eclampsia? Evidence from the
Collaborative
Eclampsia
Trial. Lancet. Jun
10 1995;345(8963):145563. [Medline].
22. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned
from recent trials. Am J Obstet Gynecol. Jun 2004;190(6):1520-6. [Medline].
23. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and
eclampsia. Obstet Gynecol. Nov 1998;92(5):883-9. [Medline].

24. Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe
hypertension in pregnancy: meta-analysis. BMJ. Oct 25 2003;327(7421):95560. [Medline].
25. Creasy RK, Resnik R, Iams JD. Maternal-Fetal Medicine: Principles and
Practice. 5th ed. 2004:859-899.
26. Martin JN Jr, Perry KG Jr, Blake PG, et al. Better maternal outcomes are
achieved with dexamethasone therapy for postpartum HELLP (hemolysis,
elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet
Gynecol. Nov 1997;177(5):1011-7. [Medline].
27. Martin JN Jr, Thigpen BD, Rose CH, et al. Maternal benefit of high-dose
intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet
Gynecol. Sep 2003;189(3):830-4. [Medline].